INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,398 | – | 279 | – | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 21 | +133.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -73.5% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 34 | -8.1% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 37 | -46.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | 0.0% | 69 | +27.8% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +28.6% | 54 | -40.7% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +250.0% | 91 | +102.2% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | +73.1% | 0.00% | – |
| Q3 2020 | $1,000 | – | 26 | +44.4% | 0.00% | – |
| Q2 2020 | $0 | – | 18 | -14.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 21 | -63.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |